Ir a industrias

Salud

Asesoramiento crítico en su proceso

Los avances tecnológicos son cada vez mayores, lo que desafía el status quo del sector sanitario que esta avanzando a pasos agigantados. Pero en una industria tan regulada, las asociaciones estratégicas suelen ser la clave para desarrollar con éxito los negocios. Nuestros asesores, respaldados por equipos subsectoriales en todo el mundo, utilizan su profunda experiencia en fusiones y adquisiciones, levantamiento de cpaital y mercado de acciones, asesoramiento sobre la deuda y servicios de finanzas corporativas para encontrar su ventaja competitiva, navegar por las costumbres locales y ayudarle a crear la estrategia más adecuada.

Contacte al asesor
En todo el mundo
556
deals cerrados en Salud
En todo el mundo
Explore todas nuestras transacciones en la industria
Ir a las Transacciones
Clínica Ricardo Palma has sold a 50% stake to Quirónsalud
Salud | Private Equity

Clínica Ricardo Palma has sold a 50% stake to Quirónsalud

The shareholders of Administradora Clínica Ricardo Palma S.A. (Clínica Ricardo Palma) have sold 50% of their shares to Quirónsalud for an undisclosed consideration.

Conozca más
Röntgeninstitut Aarau has been acquired by Evidia
Salud

Röntgeninstitut Aarau has been acquired by Evidia

The owners of Röntgeninstitut Aarau have sold the business to Evidia Group as part of their succession planning. The former owners will remain involved in the institute and support its future development alongside Evidia.

Conozca más
Olyos Group has acquired a controlling stake in NewScience
Salud

Olyos Group has acquired a controlling stake in NewScience

Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.

Conozca más
“Engaging Oaklins noticeably accelerated and advanced our succession process. The team managed it consistently and proactively and ensured that we had several attractive options available until the very end. This resulted in an outcome that exceeded our expectations.”

Dr. Herbert Wegmüller and Dr. Thierry Littmann

Owners, Röntgeninstitut Aarau

 Leer más 
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=PE&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Growth and continuity shape Q3 transactions

QUARTERLY M&A ACTIVITY: In Q3 2026, Oaklins clients closed 67 deals across M&A and fundraising, with buyers seeking expertise, customer relationships and new market access.

Conozca más

Contáctenos

Eduardo Campos

Eduardo Campos

Socio
Lima, Perú
Oaklins APOYO
Ver perfil Ponte en contacto
Ver nuestros asesores en todo el mundo